Evidence map›Paper›PMID 33881930›Full record

ArticleThe British journal of radiology2021

CT-based radiomics for predicting the rapid progression of coronavirus disease 2019 (COVID-19) pneumonia lesions.

Bin Zhang, Ma-Yi-di-Li Ni-Jia-Ti, Ruike Yan, Nan An, Lv Chen, Shuyi Liu, Luyan Chen, Qiuying Chen, Minmin Li, Zhuozhi Chen and 4 more

Abstract readValidation Study
In one paragraph

Article in The British journal of radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Radiomics analysis in medical imaging research.Journal of medical radiation sciences · 2023
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Bin ZhangDepartment of Radiology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Ma-Yi-di-Li Ni-Jia-TiDepartment of Radiology, The First People's Hospital of Kashi area, Kashgar, China.
Ruike YanDepartment of Radiology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Nan AnYizhun Medical AI Co., Ltd, Beijing, China.
Lv ChenDepartment of Radiology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Shuyi LiuDepartment of Radiology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Luyan ChenDepartment of Radiology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Qiuying ChenDepartment of Radiology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Minmin LiDepartment of Radiology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Zhuozhi ChenDepartment of Radiology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Jingjing YouDepartment of Radiology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Yuhao DongDepartment of Catheterization Lab, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong Provincial People's Hospital/Guangdong Academy of Medical Sciences, Guangzhou, China.
Zhiyuan XiongJinan University, Guangzhou, China.
Shuixing ZhangDepartment of Radiology, The First Affiliated Hospital of Jinan University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo develop and validate a radiomic model to predict the rapid progression (defined as volume growth of pneumonia lesions > 50% within seven days) in patients with coronavirus disease 2019 (COVID-19).

methodsPatients with laboratory-confirmed COVID-19 who underwent longitudinal chest CT between January 01 and February 18, 2020 were included. A total of 1316 radiomic features were extracted from the lung parenchyma window for each CT. The least absolute shrinkage and selection operator (LASSO), Relief, Las Vegas Wrapper (LVW), L1-norm-Support Vector Machine (L1-norm-SVM), and recursive feature elimination (RFE) were applied to select the features that associated with rapid progression. Four machine learning classifiers were used for modeling, including Support Vector Machine (SVM), Random Forest (RF), Logistic Regression (LR), and Decision Tree (DT). Accordingly, 20 radiomic models were developed on the basis of 296 CT scans and validated in 74 CT scans. Model performance was determined by the receiver operating characteristic curve.

resultsA total of 107 patients (median age, 49.0 years, interquartile range, 35-54) were evaluated. The patients underwent a total of 370 chest CT scans with a median interval of 4 days (interquartile range, 3-5 days). The combination methods of L1-norm SVM and SVM with 17 radiomic features yielded the highest performance in predicting the likelihood of rapid progression of pneumonia lesions on next CT scan, with an AUC of 0.857 (95% CI: 0.766-0.947), sensitivity of 87.5%, and specificity of 70.7%.

conclusionsOur radiomic model based on longitudinal chest CT data could predict the rapid progression of pneumonia lesions, which may facilitate the CT follow-up intervals and reduce the radiation. ADVANCES IN KNOWLEDGE: Radiomic features extracted from the current chest CT have potential in predicting the likelihood of rapid progression of pneumonia lesions on the next chest CT, which would improve clinical decision-making regarding timely treatment.

Indexed as

AdultCOVID-19Decision TreesDisease ProgressionFemaleHumansLogistic ModelsMaleMiddle AgedPandemicsPneumonia, ViralPredictive Value of TestsSARS-CoV-2Sensitivity and SpecificitySupport Vector MachineTomography, X-Ray Computed

Identifiers

PMID33881930
PMCPMC8173680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.